Are there gender-specific differences concerning quality of life in treated acromegalic patients?

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 5, 2011, Pages 300-305

  Psaras, T ^a   Honegger, J ^a   Gallwitz, B ^a   Milian, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

acromegaly; comorbidities; complaints; gender differences; quality of life

Indexed keywords

ACROMEGALY; ACROMEGALY COMORBIDITIES AND COMPLAINTS QUESTIONNAIRE; ACROMEGALY QUALITY OF LIFE QUESTIONNAIRE; ADULT; ARTHROPATHY; ARTICLE; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SEX DIFFERENCE; SHORT FORM 36; VALIDITY;

ACROMEGALY; ADULT; AGED; COMORBIDITY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SEX CHARACTERISTICS;

EID: 79955912496     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1267912     Document Type: Article

References (24)

1. Biermasz NR, van Thiel SW, Pereira AM et al,. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 2004 89 5369-5376 (Pubitemid 39518410)
2. Biermasz NR, Pereira AM, Smit JWA et al,. Morbidity after Long-Term Remission for Acromegaly: Persisting Joint-Related Complaints Cause Reduced Quality of Life. J Clin Endocrinol Metab 2005 95 2731-2739 (Pubitemid 40686317)
3. Bourdelot A, Coste J, Hazebroucq V et al,. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Eur J Endocrinol 2004 150 763-771 (Pubitemid 38961648)
4. Colao A, Ferone D, Marzullo P et al,. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004 25 102-152 (Pubitemid 38269977)
5. Daly AF, Petrossians P, Beckers A. An overview of the epidemiology and genetics of acromegaly. J Endocrinol Invest 2005 28 67-69
6. Essau CA, Lewinsohn PM, Seeley JR et al,. Gender differences in the developmental course of depression. J Affect Disord 2010 [Epub ahead of print]
7. Ezzat S, Snyder PJ, Young WF et al,. Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 1992 117 711-718
8. Figueira ML, Ouakinin S. Gender-related endocrinological dysfunction and mental disorders. Curr Opin Psychiatry 2010 23 369-372
9. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999 2 29-41
10. Maison P, Tropeano AI, Macquin-Mavier I et al,. Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. J Clin Endocrinol Metab 2007 92 1743-1747 (Pubitemid 46997181)
11. Mallik S, Spertus JA, Reid KJ et al,. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 2006 166 876-883
12. Melmed S, Colao A, Barkan A et al,. Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 2009 94 1509-1517
13. Nabarro JD. Acromegaly. Clin Endocrinol 1987 26 481-512 (Pubitemid 17036415)
14. Norris CM, Hegadoren K, Pilote L. Depression symptoms have greater impact on the 1-year health related quality of life outcomes of women post-myocardial infarction compared to men. Eur J Cardiovasc Nurs 2007 6 92-98 (Pubitemid 46759517)
15. Psaras T, Milian M, Hattermann V et al,. Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly [accepted for publication. Journal of Endocrinological Investigation 2010]
16. Psaras T, Milian M, Hattermann V et al,. Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement? Acta Neurochir 2010 152 271-278
17. Rajasoorya C, Holdaway IM, Wrightson P et al,. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 1994 41 95-102 (Pubitemid 24232533)
18. Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U et al,. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 2010 74 1265-1273
19. Serri O, Robert F, Comtois R et al,. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia. Clin Endocrinol 1987 27 429-436 (Pubitemid 17148598)
20. Trepp R, Everts R, Stettler C et al,. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clin Endocrinol 2005 63 103-110 (Pubitemid 40966410)
21. van Haren-Willems J, Heijdra Y. Increasing evidence for gender differences in chronic obstructive pulmonary disease. Womens Health (Lond Engl) 2010 6 595-600
22. Ware JE Jr, Sherbourne CD. The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection. Medical Care 1992 30 473-483
23. Webb SM, Prieto L, Badia X et al,. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 2002 57 251-258 (Pubitemid 34989102)
24. Zalihi A, Markoti V, Zalihi D et al,. Gender and quality of life after cerebral stroke. Bosn J Basic Med Sci 2010 10 94-99